Corpus Intelligence IC Memo — JACKSONVILLE MEMORIAL HOSPITAL 2026-04-26 15:11 UTC
IC Memo — JACKSONVILLE MEMORIAL HOSPITAL
Investment Committee Memorandum | IL | 106 beds | Grade C | EBITDA uplift $4.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

JACKSONVILLE MEMORIAL HOSPITAL

CCN 140058 | MORGAN, IL | 106 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

JACKSONVILLE MEMORIAL HOSPITAL is a 106-bed suburban community hospital in MORGAN, IL with $61.2M in net patient revenue and a -7.0% operating margin. The hospital serves a payer mix of 37.1% Medicare, 1.0% Medicaid, and 61.9% commercial.

Thesis: Undervalued. Our ML models identify $4.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.0% to 0.3% (+736bps).

Net Revenue HCRIS$61.2M
Current EBITDA COMPUTED$-4.3M
Operating Margin COMPUTED-7.0%
Occupancy HCRIS28.3%
Revenue / Bed COMPUTED$577K
Net-to-Gross HCRIS24.7%
Distress Probability ML53.1%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
80
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -7.0% places it below the state median. Among 80 size-comparable peers (53-212 beds), the median margin is -7.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (53-212), prioritizing same-state peers. 80 hospitals in the comp set.

HospitalStateBedsRevenueMargin
JACKSONVILLE MEMORIAL HOSPITAL (Target)IL106$61.2M-7.0%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
NORTHWESTERN LAKE FOREST HOSPIIL124$494.3M-13.8%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
DELNOR-COMMUNITY HOSPITALIL149$441.4M6.4%
METHODIST MEDICAL CTR OF ILLINIL203$381.6M-7.8%
GOOD SHEPHERD HOSPITALIL176$375.2M20.0%
JAVON BEA HOSPITALIL194$364.4M10.0%
SWEDISH COVENANT HEALTHIL173$363.5M-3.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.3M+210bp18mo
Cost to Collect4.5%2.5%$1.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$744K+122bp9mo
Clean Claim Rate88.0%96.0%$39K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.3M
Cost to Collect
$1.2M
Denial Rate Reduction
$1.2M
A/R Days Reduction
$744K
Clean Claim Rate
$39K
Total EBITDA Uplift$4.5M
Current EBITDA$-4.3M
+ RCM Uplift+$4.5M
Pro Forma EBITDA$196K
Current Margin-7.0%
Pro Forma Margin0.3%
WC Released (1x)$2.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.6M$16.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.6M$16.1M0.00x-100.0%
Bull Case9.0x11.0x$-6.0M$28.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.0M$29.7M0.00x-100.0%
Bear Case11.0x10.0x$-7.3M$-3.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.3M$-6.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 28.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 53.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 80 hospitals with 53-212 beds
  • Same-state prioritization (n=81)
  • Comp margins: P25=-20.8% / P50=-7.8% / P75=6.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.